These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35339437)

  • 1. Of axons that struggle to make ends meet: Linking axonal bioenergetic failure to programmed axon degeneration.
    Babetto E; Beirowski B
    Biochim Biophys Acta Bioenerg; 2022 Jun; 1863(5):148545. PubMed ID: 35339437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging evidence for compromised axonal bioenergetics and axoglial metabolic coupling as drivers of neurodegeneration.
    Beirowski B
    Neurobiol Dis; 2022 Aug; 170():105751. PubMed ID: 35569720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Programmed axon death, synaptic dysfunction and the ubiquitin proteasome system.
    Coleman MP; Ribchester RR
    Curr Drug Targets CNS Neurol Disord; 2004 Jun; 3(3):227-38. PubMed ID: 15180483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mislocalization of neuronal mitochondria reveals regulation of Wallerian degeneration and NMNAT/WLD(S)-mediated axon protection independent of axonal mitochondria.
    Kitay BM; McCormack R; Wang Y; Tsoulfas P; Zhai RG
    Hum Mol Genet; 2013 Apr; 22(8):1601-14. PubMed ID: 23314018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice.
    Mi W; Beirowski B; Gillingwater TH; Adalbert R; Wagner D; Grumme D; Osaka H; Conforti L; Arnhold S; Addicks K; Wada K; Ribchester RR; Coleman MP
    Brain; 2005 Feb; 128(Pt 2):405-16. PubMed ID: 15644421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD
    Alexandris AS; Koliatsos VE
    Antioxid Redox Signal; 2023 Dec; 39(16-18):1167-1184. PubMed ID: 37503611
    [No Abstract]   [Full Text] [Related]  

  • 7. The Drama of Wallerian Degeneration: The Cast, Crew, and Script.
    Zhang K; Jiang M; Fang Y
    Annu Rev Genet; 2021 Nov; 55():93-113. PubMed ID: 34351802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Atypical SCF-like Ubiquitin Ligase Complex Promotes Wallerian Degeneration through Regulation of Axonal Nmnat2.
    Yamagishi Y; Tessier-Lavigne M
    Cell Rep; 2016 Oct; 17(3):774-782. PubMed ID: 27732853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse cellular and molecular modes of axon degeneration.
    Neukomm LJ; Freeman MR
    Trends Cell Biol; 2014 Sep; 24(9):515-23. PubMed ID: 24780172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axon death signalling in Wallerian degeneration among species and in disease.
    Llobet Rosell A; Neukomm LJ
    Open Biol; 2019 Aug; 9(8):190118. PubMed ID: 31455157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms in the initiation phase of Wallerian degeneration.
    Chang B; Quan Q; Lu S; Wang Y; Peng J
    Eur J Neurosci; 2016 Aug; 44(4):2040-8. PubMed ID: 27062141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-axonal calcium changes after axotomy in wild-type and slow Wallerian degeneration axons.
    Adalbert R; Morreale G; Paizs M; Conforti L; Walker SA; Roderick HL; Bootman MD; Siklós L; Coleman MP
    Neuroscience; 2012 Dec; 225():44-54. PubMed ID: 22960623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal autophagy and axon degeneration.
    Wang Y; Song M; Song F
    Cell Mol Life Sci; 2018 Jul; 75(13):2389-2406. PubMed ID: 29675785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration.
    Loreto A; Hill CS; Hewitt VL; Orsomando G; Angeletti C; Gilley J; Lucci C; Sanchez-Martinez A; Whitworth AJ; Conforti L; Dajas-Bailador F; Coleman MP
    Neurobiol Dis; 2020 Feb; 134():104678. PubMed ID: 31740269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired axonal degeneration and regeneration: Recent insights and clinical correlations.
    Benarroch EE
    Neurology; 2015 May; 84(20):2076-85. PubMed ID: 25904690
    [No Abstract]   [Full Text] [Related]  

  • 16. Axonal energy metabolism, and the effects in aging and neurodegenerative diseases.
    Yang S; Park JH; Lu HC
    Mol Neurodegener; 2023 Jul; 18(1):49. PubMed ID: 37475056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The challenges of axon survival: introduction to the special issue on axonal degeneration.
    Coleman MP
    Exp Neurol; 2013 Aug; 246():1-5. PubMed ID: 23769907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial dysfunction as a trigger of programmed axon death.
    Merlini E; Coleman MP; Loreto A
    Trends Neurosci; 2022 Jan; 45(1):53-63. PubMed ID: 34852932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD and axon degeneration: from the Wlds gene to neurochemistry.
    Wang J; He Z
    Cell Adh Migr; 2009; 3(1):77-87. PubMed ID: 19372760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms for the maintenance and regulation of axonal energy supply.
    Chamberlain KA; Sheng ZH
    J Neurosci Res; 2019 Aug; 97(8):897-913. PubMed ID: 30883896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.